Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Nanomedicine & Nanotechnology Open Access Research Article 2 min read

Exosome Nanomedicine for Cancer Therapy

Sheikhhossein HH
ISSN: 2574-187X  10.23880/nnoa-16000346  Received: July 29, 2025  Published: September 30, 2025
  views
PDF
Keywords
Exosomes Nanomedicine Biological Nanocarriers Immune Cell-Derived Vesicles Drug Delivery
Abstract

In recent decades, with the discovery of nanomedicine, new therapeutic strategies have been employed. Exosomebased therapies represent a promising platform for precision drug delivery, particularly in cancer treatment. These tiny vesicles are released by almost all types of cells, and due to their unique characteristics such as the ability to cross biological barriers, long circulation time, and active tissue targeting, they could be superior alternatives to synthetic drug carriers.

Editorial

A New Horizon in Cancer Nanotherapeutics

In recent decades, with the discovery of nanomedicine, new therapeutic strategies have been employed. Exosome- based therapies represent a promising platform for precision drug delivery, particularly in cancer treatment. These tiny vesicles are released by almost all types of cells, and due to their unique characteristics such as the ability to cross biological barriers, long circulation time, and active tissue targeting, they could be superior alternatives to synthetic drug carriers.

Abbreviations

RNA: Ribonucleic Acid; SCLC: Small-Cell Lung Carcinoma.

Introduction

Challenges and Futures Prospects

Despite all the promising aforementioned applications of exosomes, there are several challenges in this field of study. Firstly, the isolation and purification of exosomes remain difficult processes. Even before that, scaling up production to clinical levels is a major technical bottleneck. Secondly, standardization is complex due to the biological variability shaped by their parental cells.

Nevertheless, it is possible to overcome these challenges by employing innovative technologies such as microfluidic systems, scalable bioreactors, and synthetic biology tools. Future nanomedicine aims to provide personalized, targeted treatments using patient-specific exosomes to minimize toxicity.

Conclusion

Exosomes, with their biocompatibility, targeted delivery, and versatility, promise to revolutionize cancer therapy as key components of next-generation treatments. It will take cooperative, multidisciplinary research that links immunology, materials science, molecular biology, and clinical trials to advance this frontier. With continued work and creativity, I think exosome-based treatments will soon make their way from the lab to the clinic.

Cite this article

BibTeX
APA
RIS
@article{sheikhhossein2025,
  title   = {Exosome Nanomedicine for Cancer Therapy},
  author  = {Sheikhhossein HH},
  journal = {Nanomedicine & Nanotechnology Open Access},
  year    = {2025},
  volume  = {10},
  number  = {3},
  doi     = {10.23880/nnoa-16000346}
}
Sheikhhossein HH (2025). Exosome Nanomedicine for Cancer Therapy. Nanomedicine & Nanotechnology Open Access, 10(3). https://doi.org/10.23880/nnoa-16000346
TY  - JOUR
TI  - Exosome Nanomedicine for Cancer Therapy
AU  - Sheikhhossein HH
JO  - Nanomedicine & Nanotechnology Open Access
PY  - 2025
VL  - 10
IS  - 3
DO  - 10.23880/nnoa-16000346
ER  -